CME ON DEMAND
Earn up to 14.0 AMA PRA Category 1 Credits and achieve your Maintenance of Certification (MOC) SA-CME requirements (25 SA-CME required every three years) by earning up to 14.0 SA-CME credits upon completion of this course.
Expiring December 31, 2024, please claim your cme credit for this course no later than December 31, 2024. Instant access at your convenience anytime, anywhere.
Purchase On Demand Access Here
Already Enrolled in previous program? Click HERE to log-in to the CME On Demand
CME ON DEMAND: PET and PET/CT
Earn up to 13.75 AMA PRA Category 1 Credits and achieve your Maintenance of Certification (MOC) SA-CME requirements (25 SA-CME required every three years) by earning up to 13.75 SA-CME credits upon completion of this course.
Released 10/16/2015, Expiring September 30th, 2018, Instant access at your convenience anytime, anywhere.
Purchase On Demand Access Here
Click HERE to log-in to the CME On Demand
LIVE WEBINAR 2018: Advanced PET Imaging
Earn up to 16.0 AMA PRA Category 1 Credits by watching the course real-time from your computer or device. You will have the opportunity to send in Live Questions answered at the course. You will also receive 3 weeks access to the On-Demand Content after the course.
Purchase the Live Webinar Option Here
Click HERE to log-in to the CME Live Webinar 2018
_____________________________________
Program
| Lecture | Speaker |
|---|---|
| Importance of Patient Preparation for PET/CT (Oncology and Cardiac Sarcoidosis) | Don Yoo, MD |
| Update on Nuclear Medicine for Infection and Inflammation | Don Yoo, MD |
| Update on Radioiodine Treatment | Don Yoo, MD |
| Evaluation and Treatment of Benign Thyroid Disease | Andrew Quon, MD |
| Somatostatin Radiotherapy: The New Era of Nuclear Medicine Therapeutics | Andrew Quon, MD |
| Challenging and Instructive Abdomen and Pelvis PET/CT Review | Don Yoo, MD |
| Neuroendocrine Tumor Imaging with DOTA PET/CT | Andrew Quon, MD |
| PET/CT of the Four T’s and Esophageal Cancer | David Naeger, MD |
| Prostate Cancer PET Imaging | Andrew Quon, MD |
| Lecture | Speaker |
|---|---|
| Incidentals and Artifacts on PET/CT | David Naeger, MD |
| Comprehensive Approach to Lung Cancer Imaging | David Naeger, MD |
| When FDG PET is No Good: Situations in Which FDG PET Has Low-Sensitivity | David Naeger, MD |
| Challenging and Instructive Chest PET/CT Review | Don C. Yoo, MD |
| Pulmonary Nodules: CT and PET/CT Assessment | David Naeger, MD |
| PET/CT in Head and Neck Cancer | Don Yoo, MD |
| Metastatic Castration- Resistant Prostate Cancer | Andrew Quon, MD |
| Back to Basics Nuclear Medicine | Andrew Quon, MD |
Faculty
David M. Naeger, M.D.
Director of Radiology, Professor and Vice Chair, Department of Radiology, Denver Health
University of Colorado School of Medicine
Subspecialty Focus: Cardiac and Thoracic Imaging, Nuclear Medicine
Andrew Quon, MD
Professor
David Geffen School of Medicine at UCLA
Don C. Yoo, MD
Professor of Diagnostic Imaging, Clinician Educator
The Warren Alpert Medical School of Brown University
Director of Nuclear Medicine, The Miriam Hospital
Objectives and Accreditation
This course provides a clinical perspective of PET/CT imaging and the emerging use of Theranostic agents within Nuclear Medicine. A broad perspective on the economic, clinical, and academic aspects of the latest trends in PET/CT imaging and Nuclear Medicine therapy will be presented.
At the conclusion of this course, participants will be able to:
• Describe new developments in the merger of diagnostic and therapeutic radioligands for PET/CT imaging and therapy with specific focus on DOTA, PSMA, and PRRT
• Describe the logistics of bringing these new diagnostic and therapeutic technologies to clinical practice
• Identify the key clinical indications for new emerging tracers for Neuroendocrine Tumor and Prostate cancer using somatostatin receptor and PSMA PET/CT imaging
• Review and discuss the standard-of-care clinical application and advanced interpretation of FDG PET/CT
With the recent approval by CMS Medicare for DOTATATE (NETSPOT) PET/CT and the rapid international adoption of targeted Lu-177 based therapies for neuroendocrine and prostate cancers, it is clear that Nuclear Medicine and PET/CT are entering into a new era. New diagnostic and therapeutic agents with remarkable sensitivity and specificity are revolutionizing Nuclear Medicine and Oncology. This course will highlight the latest targeted imaging agents for neuroendocrine and prostate cancers (Ga-68 DOTATATE and Ga-68 PSMA PET/CT) as well as review important core concepts in PET/CT imaging and therapeutic Nuclear Medicine.
Target Audience
This course is intended for practicing radiologists, nuclear medicine physicians and radiologic nurses, physician assistants, technologists, residents, fellows and others who are interested in the clinical applications of PET and PET/CT.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and CME Science. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this enduring activity for 14.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by PIM for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
How to Claim your CME Certificate instruction video on www.cmeuniversity.com
Terms, Refund and Privacy Policies, Technical Requirements
THESE PRESENTATIONS ARE FOR THE USE OF On-Demand CONTENT PURCHASES ONLY. By accessing the presentations, you agree that you are an authorized user and you further agree to view and use the contents for your personal, educational use only. CME Science and “PET and PET/CT”, expressly disclaims all liability associated with any other use, or with any actions taken or not taken based on the contents of this presentation. Any reproduction, permanent storage, or retransmission of presentations is prohibited without the prior written permission of CME Science.
Privacy Policy: Information provided is strictly for CME Science use and is not shared with any other entity, public or private, for any reason. We will not sell or give any lists or other data that we may obtain and we do not purchase such information from other sources. CME Science uses appropriate controls to ensure that credit card and personal information is kept secure.
Refund Policy: Cancellations can only be made within 24 hours of purchase. Please note: If you have applied for CME credit during the 24 hour period “NO” refunds will be available. Refunds will be given less a $100.00 administrative fee.
Questions about CME Science’s Privacy and Refund policy please contact CME Science by emailing info@cmescience.com or by phone at 650-440-4424